KD Logo

Mizuho analysts initates a Buy rating for Kura Oncology Inc (KURA)

In a filing, Kura Oncology Inc revealed its Chief Medical Officer DALE STEPHEN unloaded Company’s shares for reported $0.1 million on Jan 30 ’24. In the deal valued at $21.55 per share,4,825 shares were sold. As a result of this transaction, DALE STEPHEN now holds 38,817 shares worth roughly $0.78 million.

Then, DALE STEPHEN sold 7,158 shares, generating $127,416 in total proceeds. Upon selling the shares at $17.80, the Chief Medical Officer now owns 43,642 shares.

Before that, DOYLE THOMAS JAMES sold 2,318 shares. Kura Oncology Inc shares valued at $41,262 were divested by the SVP, Finance & Accounting at a price of $17.80 per share. As a result of the transaction, DOYLE THOMAS JAMES now holds 48,093 shares, worth roughly $0.96 million.

Mizuho initiated its Kura Oncology Inc [KURA] rating to a Buy in a research note published on December 22, 2023; the price target was $26. A number of analysts have revised their coverage, including BofA Securities’s analysts, who began to cover the stock in mid August with a ‘”a Buy”‘ rating. Scotiabank began covering KURA with “Sector perform” recommendation on July 27, 2023. BTIG Research started covering the stock on May 17, 2023. It rated KURA as “a Buy”.

Price Performance Review of KURA

On Monday, Kura Oncology Inc [NASDAQ:KURA] saw its stock jump 2.09% to $20.06. Over the last five days, the stock has gained 10.28%. Kura Oncology Inc shares have risen nearly 39.50% since the year began. Nevertheless, the stocks have risen 108.52% over the past one year. While a 52-week high of $24.17 was reached on 03/11/24, a 52-week low of $7.41 was recorded on 01/23/24. SMA at 50 days reached $20.62, while 200 days put it at $13.87. A total of 0.51 million shares were traded, compared to the trading of 0.82 million shares in the previous session.

Levels Of Support And Resistance For KURA Stock

The 24-hour chart illustrates a support level at 19.74, which if violated will result in even more drops to 19.41. On the upside, there is a resistance level at 20.36. A further resistance level may holdings at 20.66. The Relative Strength Index (RSI) on the 14-day chart is 53.61, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.64, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 14.62%. Stochastics %K at 70.50% indicates the stock is a holding.

The most recent change occurred on January 31, 2023 when Stifel began covering the stock and recommended ‘”a Buy”‘ rating along with a $25 price target.

Most Popular

[the_ad id="945"]